Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis.
Nutritional factors and aging in demyelinating diseases.
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
Tumefactive idiopathic inflammatory demyelinating lesions: a diagnostic challenge.
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
Vision and vision-related outcome measures in multiple sclerosis.
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica.
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
iNKT-cells and their ligands: focus on multiple sclerosis.
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Visualization of the medial forebrain bundle using diffusion tensor imaging.
Gender differences in caregiver strain, needs for support, social support, and quality of life among spousal caregivers of persons with multiple sclerosis.
[Immunomodulatory effect of Huangqi glycoprotein on mice with experimental autoimmune encephalomyelitis].
Patient assessment within the context of healthcare delivery packages: A comparative analysis.
Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells.
Erratum to: Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-κB inhibition.
Erratum to Myelin water mapping by spatially regularized longitudinal relaxographic imaging at high magnetic fields (Magn Reson Med 2014;71:375-387).
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ(9)-tetrahydrocannabinol acting through CB1 receptors.
Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.
Pages
« first
‹ previous
…
623
624
625
626
627
628
629
630
631
…
next ›
last »